News BMS' Opdivo still streets ahead of Merck rival BMS to refocus operations, according to Q3 results.
News NICE rejects Keytruda in lung cancer, points to price and da... Cancer immunotherapy too expensive.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
